BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Porto WF. Virtual screening of peptides with high affinity for SARS-CoV-2 main protease. Comput Biol Med 2021;133:104363. [PMID: 33862305 DOI: 10.1016/j.compbiomed.2021.104363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao K, Wang R, Chen J, Cheng L, Frishcosy J, Huzumi Y, Qiu Y, Schluckbier T, Wei X, Wei GW. Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chem Rev 2022. [PMID: 35594413 DOI: 10.1021/acs.chemrev.1c00965] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
2 Hernández González JE, Eberle RJ, Willbold D, Coronado MA. A Computer-Aided Approach for the Discovery of D-Peptides as Inhibitors of SARS-CoV-2 Main Protease. Front Mol Biosci 2022;8:816166. [DOI: 10.3389/fmolb.2021.816166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sadiq IZ, Muhammad A, Mada SB, Ibrahim B, Umar UA. Biotherapeutic effect of cell-penetrating peptides against microbial agents: a review. Tissue Barriers 2021;:1995285. [PMID: 34694961 DOI: 10.1080/21688370.2021.1995285] [Reference Citation Analysis]
4 Kreutzer AG, Krumberger M, Diessner EM, Parrocha CMT, Morris MA, Guaglianone G, Butts CT, Nowick JS. A cyclic peptide inhibitor of the SARS-CoV-2 main protease. Eur J Med Chem 2021;221:113530. [PMID: 34023738 DOI: 10.1016/j.ejmech.2021.113530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]